Published in Transfusion on September 01, 2006
Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood (2009) 2.05
The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions. MAbs (2010) 1.86
Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease. Transfusion (2011) 1.55
Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients. Asian J Transfus Sci (2014) 1.52
Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood (2011) 1.48
Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol (2007) 1.09
Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major. Am J Hematol (2011) 1.07
Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest (2009) 1.04
Responder individuality in red blood cell alloimmunization. Transfus Med Hemother (2014) 1.03
Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion (2009) 1.00
Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sang (2010) 0.94
Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models. Transfus Med Hemother (2014) 0.91
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion (2009) 0.91
Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies. Transfusion (2013) 0.89
Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity. Transfusion (2011) 0.88
Study of possible clinical and laboratory predictors of alloimmunization against red blood cell antigens in cancer patients. Rev Bras Hematol Hemoter (2013) 0.88
Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion (2012) 0.87
Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study. BMJ Open (2012) 0.85
Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood (2010) 0.85
Platelet transfusion - the new immunology of an old therapy. Front Immunol (2015) 0.84
Transfusion of older red blood cell units, cytokine burst and alloimmunization: a case-control study. Rev Bras Hematol Hemoter (2015) 0.83
The Nlrp3 Inflammasome Does Not Regulate Alloimmunization to Transfused Red Blood Cells in Mice. EBioMedicine (2016) 0.83
The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders. Transfus Med Hemother (2014) 0.83
Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model. Mol Immunol (2011) 0.83
The association of CD81 polymorphisms with alloimmunization in sickle cell disease. Clin Dev Immunol (2013) 0.83
Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way? Transfus Med Hemother (2014) 0.82
Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease. Am J Hematol (2015) 0.82
Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model. Transfusion (2011) 0.80
Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens. Transfus Med Rev (2013) 0.78
Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice. J Immunol (2017) 0.77
Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion. Haematologica (2015) 0.76
Minor antigens on transfused RBCs crossprime CD8 T cells but do not induce full effector function. Am J Transplant (2011) 0.76
Enhancement of Antibody Titre and Development of Additional Red Cell Alloantibodies Following Intrauterine Transfusion. Indian J Hematol Blood Transfus (2013) 0.75
Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India. Adv Hematol (2015) 0.75
Red blood cell transfusion: a clinical practice guideline from the AABB*. Ann Intern Med (2012) 5.77
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood (2010) 3.03
Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA (2008) 2.65
The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion (2009) 2.56
A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion (2009) 2.26
Blood donors and factors impacting the blood donation decision. Transfus Med Rev (2002) 2.25
Noninfectious serious hazards of transfusion. Anesth Analg (2009) 2.21
Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood (2009) 2.05
Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion (2009) 2.04
Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood (2011) 1.92
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion (2008) 1.77
Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood (2005) 1.77
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer (2010) 1.63
Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization? Transfusion (2009) 1.57
Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood (2007) 1.55
Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease. Transfusion (2011) 1.55
Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood (2011) 1.48
The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion (2010) 1.44
Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model. Blood (2013) 1.41
Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus Med Rev (2007) 1.40
ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci (2010) 1.32
Description and investigation of white particulate matter in additive solution-1 red blood cell units. Transfusion (2004) 1.27
CMV DNA is rarely detected in healthy blood donors using validated PCR assays. Transfusion (2003) 1.23
The PAX8/PPARgamma fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARgamma inhibition. Oncogene (2004) 1.20
Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr (2010) 1.10
Transfusion-related acute lung injury: from bedside to bench and back. Blood (2010) 1.08
A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion (2011) 1.07
Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion (2010) 1.04
Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest (2009) 1.04
Strain-specific red blood cell storage, metabolism, and eicosanoid generation in a mouse model. Transfusion (2013) 1.03
Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis (2010) 1.03
IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity. Blood (2011) 1.02
Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure. Transfusion (2010) 1.01
Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion (2007) 1.01
Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006. Transfusion (2009) 1.01
Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics (2009) 1.01
Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion (2009) 1.00
Racial differences in motivators and barriers to blood donation among blood donors. Arch Pathol Lab Med (2009) 0.99
Facilitating T-cell immune reconstitution after haploidentical transplantation in adults. Blood Cells Mol Dis (2004) 0.98
Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions. Blood (2008) 0.97
Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety. Transfusion (2006) 0.96
Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Transfusion (2013) 0.96
Chronic GvHD decreases antiviral immune responses in allogeneic BMT. Blood (2007) 0.96
The potential impact of selective donor deferrals based on estimated blood volume on vasovagal reactions and donor deferral rates. Transfusion (2010) 0.95
Pathophysiology of early trauma-induced coagulopathy: emerging evidence for hemodilution and coagulation factor depletion. J Trauma (2011) 0.95
Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells. Transfusion (2008) 0.95
2-(Diethylhexyl)phthalate in blood bags: is this a public health issue? Transfusion (2011) 0.94
Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity. J Immunol (2011) 0.93
Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells. Transfusion (2011) 0.93
Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced transfusions. Transfus Med Rev (2011) 0.93
Blood donation and blood transfusion: special considerations for African Americans. Transfus Med Rev (2008) 0.91
An automatable format for accurate immunohematology testing by flow cytometry. Transfusion (2003) 0.91
The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy. Biomaterials (2013) 0.91
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion (2009) 0.91
Host and donor immune responses contribute to antiviral effects of amotosalen-treated donor lymphocytes following early posttransplant cytomegalovirus infection. J Immunol (2008) 0.90
Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes. Blood (2007) 0.90
Transfusion management of trauma patients. Anesth Analg (2009) 0.90
Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcγ receptors in a murine model. Transfusion (2012) 0.90
Motivators and barriers to blood donation in African American college students. Transfus Apher Sci (2009) 0.89
Addition of ascorbic acid solution to stored murine red blood cells increases posttransfusion recovery and decreases microparticles and alloimmunization. Transfusion (2013) 0.89
Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies. Transfusion (2013) 0.89
Demographic patterns of blood donors and donations in a large metropolitan area. J Natl Med Assoc (2011) 0.88
Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity. Transfusion (2011) 0.88
Unappreciated risk factors for transplant patients: HLA antibodies in blood components. Hum Immunol (2004) 0.87
Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion (2012) 0.87
Immunization to minor histocompatibility antigens on transfused RBCs through crosspriming into recipient MHC class I pathways. Blood (2005) 0.87
Epidemiological Profiles of Foreign-Born and US-Born Hispanic Blood Donors in a Major Metropolitan Area in the United States. J Blood Transfus (2012) 0.87
Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A. Transfusion (2007) 0.87
Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells. Transplantation (2006) 0.87
Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation. J Immunol (2003) 0.86
Blood donations motivators and barriers: a descriptive study of African American and white voters. Transfus Apher Sci (2012) 0.86
Minority donation in the United States: challenges and needs. Curr Opin Hematol (2010) 0.86
Fatigue shifts and scatters heart rate variability in elite endurance athletes. PLoS One (2013) 0.86
Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature. Transfusion (2014) 0.86
Frequency of glucose-6-phosphate dehydrogenase-deficient red blood cell units in a metropolitan transfusion service. Transfusion (2012) 0.85
An autoanti-Kp b immunoglobulin M that simulates antigen suppression. Transfusion (2009) 0.85
Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood (2010) 0.85
Leukoreduction filtration of blood with sickle cell trait. Transfus Med Rev (2004) 0.84
Demographic differences in estimated blood donor eligibility prevalence in the United States. Transfusion (2011) 0.84
Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff. Transfusion (2010) 0.84
Metabolomics profile comparisons of irradiated and nonirradiated stored donor red blood cells. Transfusion (2014) 0.84